Cardiovascular disease prevention: Matching evidence-based algorithms with individualized care

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 4, 2013, Pages 321-323

  Madanieh, R ^a   Hasan, R K ^b   Anusionwu, O F ^c   Blumenthal, R S ^b   Blaha, M J ^b  

^a Atlantic Health   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; NUMBERS NEEDED TO TREAT; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

ALGORITHMS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDIVIDUALIZED MEDICINE; PRIMARY PREVENTION;

EID: 84875441500     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.3     Document Type: Article

References (5)

1. Aberle, D.R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395-409 (2011).
2. Mihaylova, B. et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized trials. Lancet 380, 581-590 (2012).
3. Ridker, P.M. et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195-2207 (2008).
4. Blaha, M.J. et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 378, 684-692 (2011).
5. Arad, Y., Spadaro, L.A., Roth, M., Newstein, D. & Guerci, A.D. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J. Am. Coll. Cardiol. 46, 166-172 (2005).